Lower Doses of Antibiotics and Shorter Treatment Durations Just As Effective on Children with Pneumonia: Study
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Lawsuit Alleges Avelox Side Effects Caused Peripheral Neuropathy January 20, 2015 Irvin Jackson Add Your Comments Bayer Healthcare Pharmaceuticals faces a new product liability lawsuit, which alleges that side effects of Avelox caused an Illinois woman to suffer severe and long-lasting nerve damage, known as peripheral neuropathy, after using the popular antibiotic. The complaint (PDF) was filed last week by Jeanne Bullard, in the U.S. District Court for the Southern District of Illinois. According to allegations raised in the lawsuit, Bullard was prescribed a 10-day treatment of the antibiotic Avelox in January 2013, after which she suffered began to develop peripheral neuropathy, which now appears to be permanent. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The case joins a growing number of peripheral neuropathy lawsuits filed nationwide, against Bayer and the makers of other antibiotics that are part of a class of drugs known as fluoroquinolones, which also includes Levaquin, Cipro and others. All of the complaints raise similar allegations that false and misleading warnings were provided about the risk of antibiotic nerve problems. Peripheral neuropathy is a medical condition that involves damage to the nerves, which may impair sensation, movement and other aspects of health. Symptoms may include pain, burning, tingling, numbness, weakness and sensitivity to light touches, temperature and motion in the arms and legs. While warnings provided with Avelox, Levaquin, Cipro and other fluoroquinolones have indicated that users may face a risk of peripheral neuropathy, for years the drug makers indicated that the problems were rare and failed to adequately disclose that users may be left with irreversible nerve damage, according to Bullard’s complaint. In August 2013, the FDA required drug makers to provide stronger warnings about the peripheral neuropathy risk with fluoroquinolones, indicating problems may last for months or years after an individual stops taking the drug. The new label now warns patients to contact their doctors and consider switching to a different class of antibiotics if they experience symptoms of peripheral neuropathy. Similar Levaquin lawsuits and Cipro lawsuits are also being pursued throughout the U.S. by users of those other popular fluoroquinolones, raising nearly identical allegations that indicate the drug makers placed their desire for profits before consumer safety by withholding adequate warnings about the risk of peripheral neuropathy for years. Bullard’s lawsuit claims that the manufacturers knew or should have known about the risk of permanent nerve damage since at least 2003. “A scientific review by the FDA of the adverse events in the FDA Adverse Event database in 2003 concerning Avelox and other fluoroquinolones revealed numerous reports of long-term peripheral neuropathy,” the lawsuit states. However, the label warning called such cases rare and did not mention long-term risks. “Thus, rather than warning patients and physician that the use of Avelox may result in permanent nerve damage, Defendants instead adopted a warning that misleadingly indicated such damage was rare and failed to make any mention of the risk of permanent nerve damage.” Bullard presents claims for strict liability, failure to warn, breach of warranty, negligence, fraud, negligent misrepresentation, fraudulent concealment, and negligent infliction of emotional distress, seeking both compensatory and punitive damages. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Antibiotics, Avelox, Bayer, Illinois, Merck, Nerve Damage, Peripheral Neuropathy Image Credit: | More Antibiotic Lawsuit Stories New Antiseptic Treatment Could Reduce Antibiotic Use For UTIs: Study March 24, 2022 Lower Doses of Antibiotics and Shorter Treatment Durations Just As Effective on Children with Pneumonia: Study November 30, 2021 Levaquin, Similar Antibiotics May Increase Risk of Cardiac Arrest in Hemodialysis Patients: Study October 26, 2021 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Brain Tumor Symptoms Create Lifelong Meningioma Fears Among Women (Posted: today) Women across the U.S. are now pursuing product liability lawsuits and medical monitoring class action claims to secure compensation for potential brain tumor symptoms and side effects linked to the use of Depo-Provera. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (09/03/2025)Pfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025) Safety Problems With Roblox and Discord Endangered Young Girl: Lawsuit (Posted: yesterday) A Texas mother is pursuing a lawsuit against Roblox and Discord, claiming the design of the apps allow sexual predators to access and groom young children. MORE ABOUT: ROBLOX LAWSUITLawsuit Alleges Roblox Lacks Safeguards To Protect Children From Sexual Predators (09/11/2025)Roblox Age Verification Technology To Be Implemented Amid Child Exploitation Lawsuits (09/09/2025)Roblox Kidnapping Lawsuit Filed After Child Was Abducted and Sexually Trafficked (09/03/2025) Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (Posted: 2 days ago) Federal regulators are investigating whether Dupixent increases the risk of cutaneous T-cell lymphoma (CTCL), after more than 300 adverse event reports flagged cancer diagnoses among users. The FDA’s review comes as lawsuits are being pursued nationwide, alleging Sanofi and Regeneron failed to warn that the blockbuster eczema drug could either trigger or mask the rare blood cancer. MORE ABOUT: DUPIXENT LAWSUITDupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)Dupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025)
Lower Doses of Antibiotics and Shorter Treatment Durations Just As Effective on Children with Pneumonia: Study November 30, 2021
Levaquin, Similar Antibiotics May Increase Risk of Cardiac Arrest in Hemodialysis Patients: Study October 26, 2021
Depo-Provera Brain Tumor Symptoms Create Lifelong Meningioma Fears Among Women (Posted: today) Women across the U.S. are now pursuing product liability lawsuits and medical monitoring class action claims to secure compensation for potential brain tumor symptoms and side effects linked to the use of Depo-Provera. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (09/03/2025)Pfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)
Safety Problems With Roblox and Discord Endangered Young Girl: Lawsuit (Posted: yesterday) A Texas mother is pursuing a lawsuit against Roblox and Discord, claiming the design of the apps allow sexual predators to access and groom young children. MORE ABOUT: ROBLOX LAWSUITLawsuit Alleges Roblox Lacks Safeguards To Protect Children From Sexual Predators (09/11/2025)Roblox Age Verification Technology To Be Implemented Amid Child Exploitation Lawsuits (09/09/2025)Roblox Kidnapping Lawsuit Filed After Child Was Abducted and Sexually Trafficked (09/03/2025)
Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (Posted: 2 days ago) Federal regulators are investigating whether Dupixent increases the risk of cutaneous T-cell lymphoma (CTCL), after more than 300 adverse event reports flagged cancer diagnoses among users. The FDA’s review comes as lawsuits are being pursued nationwide, alleging Sanofi and Regeneron failed to warn that the blockbuster eczema drug could either trigger or mask the rare blood cancer. MORE ABOUT: DUPIXENT LAWSUITDupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)Dupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025)